-
From Research to Reality: Meet 2 Researchers Driving Drug Development Progress
Every therapy or intervention has a backstory. Long before a treatment reaches a clinic, it often begins with a grant that gives researchers the time and support to follow a promising idea. That path from lab to real life can take years, but it is how progress happens. The two researchers profiled here represent different…
-
Progress Now: Enrolling Clinical Trial Updates
Amyotrophic lateral sclerosis (ALS) Phase 1 Clinical Trial: Enrolling This trial, called LUMINA, is testing the investigational therapy AMX0114 in adults with ALS. The main goal is to evaluate safety and tolerability at different dosing levels. Inclusion criteria include: Definite ALS or probable ALS diagnosis Age 18 years or older ALS symptoms began within the…








